Head-to-head for women
CoreAge Rx vs REMEVi
CoreAge Rx and REMEVi both offer GLP-1 telehealth to women, but they make different trade-offs on PCOS and hormonal suitability, clinical oversight, price and access. Here they are side-by-side on the Metabolic-Fit Score — our women's-health rubric.
CoreAge Rx
Higher scoreRanked #1 for women · Grade A−
Metabolic-Fit / 100
Best for: Mothers who want a fixed monthly price, a real clinician rather than an intake quiz, and uninterrupted nationwide access to both semaglutide and tirzepatide while they work out the timing around pregnancy or weaning.
Visit CoreAge RxREMEVi
Ranked #31 for women · Grade C
Metabolic-Fit / 100
Best for: Mothers who want to see every plan-length tier before committing and value bilingual (EN/ES) support.
Visit REMEViThe verdict for women
CoreAge Rx edges out REMEVi on the Metabolic-Fit Score, 92 to 51 (A− vs C). Mothers who want a fixed monthly price, a real clinician rather than an intake quiz, and uninterrupted nationwide access to both semaglutide and tirzepatide while they work out the timing around pregnancy or weaning.
REMEVi is still a genuine option — a genuinely transparent tiered-pricing shop — as low as $149/mo semaglutide or $199/mo tirzepatide on the annual plan — with press mentions and bilingual support, though no postpartum or PCOS-specific content. Weigh the six women's-health factors below against your own priorities.
Side-by-side on the six factors
Both providers scored on the same women's-health rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | CoreAge Rx | REMEVi |
|---|---|---|
| Metabolic-Fit Score | 92/100 · A− | 51/100 · C |
| Overall rank | #1 | #31 |
| Semaglutide | $99/mo | $149-219/mo depending on plan length |
| Tirzepatide | $149/mo | $199-319/mo depending on plan length |
| Coverage | All 50 states | All 50 states + DC |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Yes |
Metabolic-Fit / 100
CoreAge Rx
Ranked #1 · Grade A−
What we like
- A single flat monthly rate — no teaser first month that jumps at the first refill
- A prescriber reviews your history and will actually talk through timing if you're postpartum, nursing, or planning another pregnancy
- Semaglutide and tirzepatide on one chart, so switching molecules doesn't mean switching providers
The caveats
- Not the lowest sticker price — a couple of budget compounders come in under it
- Compounded only; there's no FDA-approved brand Wegovy or Zepbound lane here
- A general metabolic program, not a dedicated OB or hormone practice
Metabolic-Fit / 100
REMEVi
Ranked #31 · Grade C
What we like
- All three plan-length tiers for both molecules are visible on the public site, no intake required
- Explicitly states the price never climbs with dose — a real flat-pricing claim, not just a marketing line
- Bilingual (English/Spanish) support with WhatsApp, plus press mentions (AP, USA Today, Fortune, Reuters)
The caveats
- No brand-name (FDA-approved) option
- No mention anywhere of pregnancy, breastfeeding, postpartum care, or PCOS
- The oral tablet option's own separate pricing tier wasn't itemized on the pages checked
Some outbound links earn MomMetabolic a referral fee at no added cost to you, walled off from the Metabolic-Fit Score. Pricing, states and verification reflect each provider's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing CoreAge Rx and REMEVi against other providers we review for women.
Or browse the full comparison hub.